SE7607389L - WAY TO REDUCE THE DOSE OF A BIOLOGICALLY ACTIVE SUBSTANCE WHILE MAINTAINING THE BIOLOGICAL EFFECT - Google Patents

WAY TO REDUCE THE DOSE OF A BIOLOGICALLY ACTIVE SUBSTANCE WHILE MAINTAINING THE BIOLOGICAL EFFECT

Info

Publication number
SE7607389L
SE7607389L SE7607389A SE7607389A SE7607389L SE 7607389 L SE7607389 L SE 7607389L SE 7607389 A SE7607389 A SE 7607389A SE 7607389 A SE7607389 A SE 7607389A SE 7607389 L SE7607389 L SE 7607389L
Authority
SE
Sweden
Prior art keywords
dose
maintaining
reduce
way
active substance
Prior art date
Application number
SE7607389A
Other languages
Swedish (sv)
Other versions
SE421042B (en
Inventor
K G Blixt
R Juhlin
M Tiru
Original Assignee
Kockums Chem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kockums Chem filed Critical Kockums Chem
Priority to SE7607389A priority Critical patent/SE421042B/en
Priority to DE19762652163 priority patent/DE2652163A1/en
Priority to CA 265827 priority patent/CA1080500A/en
Priority to DK518476A priority patent/DK518476A/en
Priority to FI763304A priority patent/FI61637C/en
Priority to NO763947A priority patent/NO146974C/en
Priority to GB48278/76A priority patent/GB1572718A/en
Priority to LU76238A priority patent/LU76238A1/xx
Priority to BE172830A priority patent/BE848892A/en
Priority to IT30032/76A priority patent/IT1064524B/en
Priority to NL7613404A priority patent/NL7613404A/en
Priority to MC761221A priority patent/MC1116A1/en
Priority to FR7636578A priority patent/FR2356430A1/en
Priority to JP670477A priority patent/JPS533512A/en
Priority to IN806/CAL/77A priority patent/IN145766B/en
Priority to ZA00773259A priority patent/ZA773259B/en
Priority to GR53602A priority patent/GR63669B/en
Priority to IL52243A priority patent/IL52243A/en
Priority to PT66663A priority patent/PT66663B/en
Priority to AU26111/77A priority patent/AU2611177A/en
Priority to AR268151A priority patent/AR221686A1/en
Priority to DD7700199726A priority patent/DD130984A5/en
Priority to ES460159A priority patent/ES460159A1/en
Priority to PL19923777A priority patent/PL199237A1/en
Publication of SE7607389L publication Critical patent/SE7607389L/en
Publication of SE421042B publication Critical patent/SE421042B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/12—Powders or granules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/015—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/04—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating
    • A61L9/046—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating with the help of a non-organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/651—The particulate/core comprising inorganic material
SE7607389A 1976-06-29 1976-06-29 WANT TO REDUCE THE QUANTITY OF BIOLOGICAL ACTIVE SUBSTANCE REQUIRED FOR SOME BIOLOGICAL EFFECT SE421042B (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
SE7607389A SE421042B (en) 1976-06-29 1976-06-29 WANT TO REDUCE THE QUANTITY OF BIOLOGICAL ACTIVE SUBSTANCE REQUIRED FOR SOME BIOLOGICAL EFFECT
DE19762652163 DE2652163A1 (en) 1976-06-29 1976-11-16 METHOD FOR REDUCING THE AMOUNT OF A BIOLOGICALLY ACTIVE SUBSTANCE WHILE MAINTAINING THE BIOLOGICAL EFFECT
CA 265827 CA1080500A (en) 1976-06-29 1976-11-16 Method and a composition for reducing the dose of a biologically active substance while maintaining its biological effect
DK518476A DK518476A (en) 1976-06-29 1976-11-17 PROCEDURE FOR REDUCING THE QUANTITY OF A BIOLOGICAL ACTIVE COMPOUND TO ACHIEVE A CERTAIN BIOLOGICAL IMPACT
FI763304A FI61637C (en) 1976-06-29 1976-11-18 SAETT ATT MINSKA DOSEN AV EN BIOLOGISKT AKTIV SUBSTANS UNDER BIBEHAOLLANDE AV DEN BIOLOGISKA EFFEKTEN
NO763947A NO146974C (en) 1976-06-29 1976-11-18 MEASURES TO AA REDUCE THE QUANTITY OF A BIOLOGICAL ACTIVE SUBSTANCE WHILE MAINTAINING THE BIOLOGICAL EFFECT
GB48278/76A GB1572718A (en) 1976-06-29 1976-11-19 Methods for reducing the doses of biologically active substances while maintaining their biological effects
LU76238A LU76238A1 (en) 1976-06-29 1976-11-19
BE172830A BE848892A (en) 1976-06-29 1976-11-29 METHOD AND COMPOSITION FOR REDUCING THE DOSE OF A BIOLOGICALLY ACTIVE SUBSTANCE WHILE MAINTAINING ITS BIOLOGICAL EFFECT,
IT30032/76A IT1064524B (en) 1976-06-29 1976-12-02 PROCEDURE AND COMPOSITION TO REDUCE THE DOSES OF A BIOLOGICALLY ACTIVE SUBSTANCE WHILE PRESERVING ITS BIOLOGICAL EFFECT
NL7613404A NL7613404A (en) 1976-06-29 1976-12-02 PROCESS FOR REDUCING THE QUANTITY OF A BIOLOGICALLY ACTIVE SUBSTANCE WHILE MAINTAINING THE BIOLOGICAL EFFECT.
MC761221A MC1116A1 (en) 1976-06-29 1976-12-03 METHOD AND COMPOSITION FOR REDUCING THE DOSE OF A BIOLOGICALLY ACTIVE SUBSTANCE WHILE MAINTAINING ITS BIOLOGICAL EFFECT
FR7636578A FR2356430A1 (en) 1976-06-29 1976-12-03 METHOD AND COMPOSITION FOR REDUCING THE DOSE OF A BIOLOGICALLY ACTIVE SUBSTANCE WHILE MAINTAINING ITS BIOLOGICAL EFFECT
JP670477A JPS533512A (en) 1976-06-29 1977-01-24 Method and composition for reducing amount of use of biologically active substance
IN806/CAL/77A IN145766B (en) 1976-06-29 1977-05-28
ZA00773259A ZA773259B (en) 1976-06-29 1977-05-30 Improvements in or relating to methods for reducing the doses of biologically active substances while maintaining the biological effects
GR53602A GR63669B (en) 1976-06-29 1977-06-01 Process of dose reduction of one biological drastic substance although conserve the biological influenier
IL52243A IL52243A (en) 1976-06-29 1977-06-03 Method for reducing the dose of a biologically active substance while maintaining the biological effect
PT66663A PT66663B (en) 1976-06-29 1977-06-14 A method for reducing the dose of a biologically active substance while maintaining the biological effect
AU26111/77A AU2611177A (en) 1976-06-29 1977-06-15 Biologically active compositions
AR268151A AR221686A1 (en) 1976-06-29 1977-06-22 METHOD OF PREPARING A COMPOSITION WITH A REDUCED AMOUNT OF A BIOLOGICALLY ACTIVE SUBSTANCE
DD7700199726A DD130984A5 (en) 1976-06-29 1977-06-27 METHOD FOR REDUCING THE AMOUNT OF A BIOLOGICALLY ACTIVE SUBSTANCE REQUIRED FOR A CERTAIN BIOLOGICAL EFFECT
ES460159A ES460159A1 (en) 1976-06-29 1977-06-28 Methods for reducing the doses of biologically active substances while maintaining their biological effects
PL19923777A PL199237A1 (en) 1976-06-29 1977-06-29 METHOD OF REDUCING THE AMOUNT OF BIOLOGICALLY ACTIVE SUBSTANCES REQUIRED TO GET SPECIFIC BIOLOGICAL ACTIVITY AND AGENTS WITH INCREASED BIOLOGICAL ACTIVITY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7607389A SE421042B (en) 1976-06-29 1976-06-29 WANT TO REDUCE THE QUANTITY OF BIOLOGICAL ACTIVE SUBSTANCE REQUIRED FOR SOME BIOLOGICAL EFFECT

Publications (2)

Publication Number Publication Date
SE7607389L true SE7607389L (en) 1977-12-30
SE421042B SE421042B (en) 1981-11-23

Family

ID=20328328

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7607389A SE421042B (en) 1976-06-29 1976-06-29 WANT TO REDUCE THE QUANTITY OF BIOLOGICAL ACTIVE SUBSTANCE REQUIRED FOR SOME BIOLOGICAL EFFECT

Country Status (24)

Country Link
JP (1) JPS533512A (en)
AR (1) AR221686A1 (en)
AU (1) AU2611177A (en)
BE (1) BE848892A (en)
CA (1) CA1080500A (en)
DD (1) DD130984A5 (en)
DE (1) DE2652163A1 (en)
DK (1) DK518476A (en)
ES (1) ES460159A1 (en)
FI (1) FI61637C (en)
FR (1) FR2356430A1 (en)
GB (1) GB1572718A (en)
GR (1) GR63669B (en)
IL (1) IL52243A (en)
IN (1) IN145766B (en)
IT (1) IT1064524B (en)
LU (1) LU76238A1 (en)
MC (1) MC1116A1 (en)
NL (1) NL7613404A (en)
NO (1) NO146974C (en)
PL (1) PL199237A1 (en)
PT (1) PT66663B (en)
SE (1) SE421042B (en)
ZA (1) ZA773259B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6026093B2 (en) * 1978-03-14 1985-06-21 住友製薬株式会社 Method for producing gefalnate-containing solid preparation
IT1103817B (en) * 1978-06-27 1985-10-14 Guaber Spa GRANULAR DEODORANT COMPOSITION FOR ASHTRAY
BE886778A (en) * 1979-12-21 1981-06-19 Glaxo Group Ltd MIXTURES OF CEPHALEXIN AND SILICON BIOXIDE TO BE INTRODUCED IN PHARMACEUTICAL CAPSULES
DK204682A (en) * 1981-05-08 1982-11-09 Wellcome Found Perfume-releasing materials
NZ204861A (en) * 1982-07-20 1986-10-08 Nat Res Dev Sustained release device:trace element incorporated in cement
HU191244B (en) * 1984-01-06 1987-01-28 Egyt Gyogyszervegyeszeti Gyar Dust mixture of high propylene-glycol content and process for producing same
HU191245B (en) * 1984-01-06 1987-01-28 Egis Gyogyszergyar,Hu Process for the production of stbale pharmaceutical preparation against ketosis
GB8413191D0 (en) * 1984-05-23 1984-06-27 Beecham Group Plc Pharmaceutical composition
EP0215136B1 (en) * 1985-09-02 1988-06-22 Artesan Pharma Gesellschaft mit beschränkter Haftung Hexetidin-containing therapeutically active agent, method for its preparation and its use as a vaginal disinfectant
GB8713263D0 (en) * 1987-06-05 1987-07-08 Unilever Plc Spheroidal silica
DE19506141A1 (en) * 1995-02-22 1996-08-29 Hoechst Ag Use of aerogels in pharmacy, cosmetics and crop protection
AU2893097A (en) * 1996-04-29 1997-11-19 Agricultural Academy Of Krakow Oral delivery form having a high absorption efficiency and method for making same
SG71877A1 (en) * 1997-12-19 2000-04-18 Johnson & Johnson Consumer Novel powder compositions
ATE462417T1 (en) * 1998-08-13 2010-04-15 Cima Labs Inc MICROEMULSIONS AS SOLID DOSE FORMS FOR ORAL ADMINISTRATION
CA2758618C (en) * 2009-04-24 2017-03-28 Omya Development Ag Particulate material for controlled release of active ingredients
EP2919903B1 (en) 2012-11-14 2020-07-22 W.R. Grace & CO. - CONN. Compositions containing a biologically active material and a non-ordered inorganic oxide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5235736B2 (en) * 1972-09-27 1977-09-10

Also Published As

Publication number Publication date
FI763304A (en) 1977-12-30
CA1080500A (en) 1980-07-01
PT66663A (en) 1977-07-01
PL199237A1 (en) 1979-07-02
DD130984A5 (en) 1978-05-24
FI61637B (en) 1982-05-31
IN145766B (en) 1978-12-16
NO146974C (en) 1983-01-26
DK518476A (en) 1977-12-30
FR2356430A1 (en) 1978-01-27
LU76238A1 (en) 1977-05-23
GB1572718A (en) 1980-07-30
JPS533512A (en) 1978-01-13
IT1064524B (en) 1985-02-18
MC1116A1 (en) 1977-08-12
SE421042B (en) 1981-11-23
ZA773259B (en) 1978-04-26
IL52243A (en) 1980-10-26
PT66663B (en) 1978-11-13
FI61637C (en) 1982-09-10
NO146974B (en) 1982-10-04
AR221686A1 (en) 1981-03-13
GR63669B (en) 1979-11-28
DE2652163A1 (en) 1978-01-12
FR2356430B1 (en) 1982-08-13
NL7613404A (en) 1978-01-02
IL52243A0 (en) 1977-08-31
AU2611177A (en) 1978-12-21
BE848892A (en) 1977-03-16
ES460159A1 (en) 1978-10-01
NO763947L (en) 1977-12-30

Similar Documents

Publication Publication Date Title
SE7607389L (en) WAY TO REDUCE THE DOSE OF A BIOLOGICALLY ACTIVE SUBSTANCE WHILE MAINTAINING THE BIOLOGICAL EFFECT
BE879918A (en) MEDICINE DISTRIBUTOR
NO150760C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AMINOTIAZOLES.
AT347588B (en) MEDICINAL ACTIVE SUBSTANCE
NO151546C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIMIDONES
NL7702728A (en) PHARMACOLOGICALLY ACTIVE SUBSTANCE OF LIP FLOWERS.
NO144785C (en) INSTRUMENT FOR DOSAGE OF SUBSTANCES INTO A WOMAN'S EGGS
NO147986C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE PHENYLETYLAMINES
SE8207520D0 (en) POROSA MATERIAL CONTAINING A BIOLOGICALLY ACTIVE SUBSTANCE
NO147718C (en) PROCEDURE FOR THE PREPARATION OF A BIOLOGICAL ACTIVE COPOLYMER
NO790523L (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL ACTIVE 2-PHENYLIMINOIMIDAZOLIDINES
NO151319C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BETA-MONO-FLUORMETHYL-BETA-ALANINE AND BETA-DIFLUORMETHYL-BETA-ALANINE COMPOUNDS
ZA772514B (en) Improvements relating to the administration of pharmaceutically active substances to animals
FI781866A (en) FORM OF THERAPEUTIC ACTIVATION OF ACTIVE THERAPEUTIC N- / 3-MERCAPTOACETYLAMINO) BENSOYL / GLYCIN.
NO156167C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE INDOLINON DERIVATIVES.
BR8009059A (en) ADMINISTRATION OF ACTIVE MEDICAL SUBSTANCE
FI791543A (en) THERAPEUTIC ACTIVE SUBSTITUTES DIBENSYLETRAR
NO147601C (en) ANALOGUE PROCEDURE FOR PREPARING THE THERAPEUTIC ACTIVE COMPOUND L-PYROGLUTAMYL-L-HISTIDYL-GLYCIN
SE7801106L (en) BIOLOGICAL ACTIVE SUBSTANCE
NO146776C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE PYRIDOBENZODIAZEPINES
SE430069B (en) SET FOR PREPARATION OF INSULABLE, BIOLOGICALLY ACTIVE SOCIETIES
DK117478A (en) BIOLOGICALLY ACTIVE SUBSTANCES CONTAINING BENZOHETEROCYCLIC COMPOUNDS
SU523652A1 (en) Cultivator for the care of forest crops
NO153102C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 9 ALFA, 11 BETA-DICHLOR-16 ALFA-METHYL-21-OXYCARBONYLDICYCLOHEXYL-METHYLOXYPREGNA-1,4-DIEN-3,20-DION.
NO782429L (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE MARKAPTOPOPANIC ACIDES